Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3FT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,737
Award facts
- Contract value 100% obligated
- $41,736.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,736.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Kesimpta (ofatumumab) 20 mg/0.4 mL pen injections. This is a non-set-aside, competitively awarded contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania location and an ultimate completion date of January 13, 2026. The delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Kesimpta is a specialty pharmaceutical product used in the treatment of multiple sclerosis, reflecting the company's established capability in delivering brand-name neurological medications to federal healthcare systems. AmerisourceBergen, operating as a subsidiary of Cencora, Inc., maintains significant federal pharmaceutical distribution contracts and regularly fulfills delivery orders for medications across multiple therapeutic domains including oncology, neurological conditions, diabetes management, and pain management. This contract exemplifies the company's role as a critical vendor in the military healthcare supply chain, delivering specialized medications to support Defense Health Agency operations and other government medical institutions.
Quick answers
Who was awarded contract SPE2DR26FG3FT?
SPE2DR26FG3FT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FG3FT worth?
The government has obligated $41,737 on SPE2DR26FG3FT.
Is contract SPE2DR26FG3FT an order under another contract?
Yes. SPE2DR26FG3FT is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3FT competed?
The extent of competition for SPE2DR26FG3FT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award